4de Bont ES, Martens A, van Raan J, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis[J]. Pediatr Res, 1993,33(4 Pt 1 ) :380-383.
5廖二元 超楚生.内分泌学[M].北京：人民卫生出版社,2001.610-611.
6Hirayama K, Yokoi Y, Sakaguchi T, et al. Platelet-activating factor, a critical mediator in the pathogenesis of dextran sulfate sodium-induced colitis in rats[J]. Dis Colon Rectum, 2003,46(1): 100-110.
7Deventer S J H. van New biological therapies in inflammatory bowel disease. Best Practice & Research Clinical[J]. Gastroenterology., 2003, 17(1): 119-130.
8徐淑云,卞如濂,陈修.药理试验方法学[M].北京:人民卫生出版社,2002.1426-1428
9Noguchi M, Hiwatashi N, Liu Z. et al. Secretion imbalance between tumor necrosis factor and its inhibitor in inflammatory bowel disease[J]. Gut, 1998, 43(2): 203-209.
10Suasnna Ricci, Giovanni Macchia, Paolo Ruggierio, et al. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii [J]. BMC Biotechnol, 2003, 3(1): 15-18.
